147 related articles for article (PubMed ID: 9609125)
1. Genetic manipulation of insulin action and beta-cell function in mice.
Lamothe B; Duvillié B; Cordonnier N; Baudry A; Saint-Just S; Bucchini D; Jami J; Joshi RL
Mol Cell Biochem; 1998 May; 182(1-2):161-8. PubMed ID: 9609125
[TBL] [Abstract][Full Text] [Related]
2. Genetically engineered mice as animal models for NIDDM.
Joshi RL; Lamothe B; Bucchini D; Jami J
FEBS Lett; 1997 Jan; 401(2-3):99-103. PubMed ID: 9013866
[TBL] [Abstract][Full Text] [Related]
3. Genetic manipulation of insulin signaling, action and secretion in mice. Insights into glucose homeostasis and pathogenesis of type 2 diabetes.
Baudry A; Leroux L; Jackerott M; Joshi RL
EMBO Rep; 2002 Apr; 3(4):323-8. PubMed ID: 11943762
[TBL] [Abstract][Full Text] [Related]
4. Unlocking the secrets of the pancreatic beta cell: man and mouse provide the key.
Hattersley AT
J Clin Invest; 2004 Aug; 114(3):314-6. PubMed ID: 15286795
[TBL] [Abstract][Full Text] [Related]
5. Understanding the pathogenesis and treatment of insulin resistance and type 2 diabetes mellitus: what can we learn from transgenic and knockout mice?
Mauvais-Jarvis F; Kahn CR
Diabetes Metab; 2000 Dec; 26(6):433-48. PubMed ID: 11173714
[TBL] [Abstract][Full Text] [Related]
6. Tissue-specific targeting of the insulin receptor gene.
Kulkarni RN; Okada T
Endocrine; 2002 Dec; 19(3):257-66. PubMed ID: 12624425
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic islets from cyclin-dependent kinase 4/R24C (Cdk4) knockin mice have significantly increased beta cell mass and are physiologically functional, indicating that Cdk4 is a potential target for pancreatic beta cell mass regeneration in Type 1 diabetes.
Marzo N; Mora C; Fabregat ME; Martín J; Usac EF; Franco C; Barbacid M; Gomis R
Diabetologia; 2004 Apr; 47(4):686-94. PubMed ID: 15298346
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of insulin receptor substrate-2 in pancreatic beta cells prevents diabetes.
Hennige AM; Burks DJ; Ozcan U; Kulkarni RN; Ye J; Park S; Schubert M; Fisher TL; Dow MA; Leshan R; Zakaria M; Mossa-Basha M; White MF
J Clin Invest; 2003 Nov; 112(10):1521-32. PubMed ID: 14617753
[TBL] [Abstract][Full Text] [Related]
9. Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1.
Nakae J; Biggs WH; Kitamura T; Cavenee WK; Wright CV; Arden KC; Accili D
Nat Genet; 2002 Oct; 32(2):245-53. PubMed ID: 12219087
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetic analysis of diabetes in mice.
Gannon M
Trends Genet; 2001 Oct; 17(10):S23-8. PubMed ID: 11585673
[TBL] [Abstract][Full Text] [Related]
11. Expression of human insulin and hybrid insulin genes in pancreatic beta cells of transgenic mice.
Bucchini D; Deltour L; Jami J
Horm Res; 1989; 32(1-3):47-52. PubMed ID: 2693315
[TBL] [Abstract][Full Text] [Related]
12. Quantitative real-time PCR detection of insulin signalling-related genes in pancreatic islets isolated from healthy cats.
Zini E; Franchini M; Osto M; Vögtlin A; Guscetti F; Linscheid P; Kaufmann K; Sigrist B; Ackermann M; Lutz TA; Reusch CE
Vet J; 2010 Mar; 183(3):287-93. PubMed ID: 19119030
[TBL] [Abstract][Full Text] [Related]
13. Beta-cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type 2 diabetes.
Matveyenko AV; Butler PC
Diabetes; 2006 Jul; 55(7):2106-14. PubMed ID: 16804082
[TBL] [Abstract][Full Text] [Related]
14. Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2.
Kido Y; Burks DJ; Withers D; Bruning JC; Kahn CR; White MF; Accili D
J Clin Invest; 2000 Jan; 105(2):199-205. PubMed ID: 10642598
[TBL] [Abstract][Full Text] [Related]
15. Beta-cell-targeted expression of a dominant-negative hepatocyte nuclear factor-1 alpha induces a maturity-onset diabetes of the young (MODY)3-like phenotype in transgenic mice.
Hagenfeldt-Johansson KA; Herrera PL; Wang H; Gjinovci A; Ishihara H; Wollheim CB
Endocrinology; 2001 Dec; 142(12):5311-20. PubMed ID: 11713231
[TBL] [Abstract][Full Text] [Related]
16. Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes.
Gunton JE; Kulkarni RN; Yim S; Okada T; Hawthorne WJ; Tseng YH; Roberson RS; Ricordi C; O'Connell PJ; Gonzalez FJ; Kahn CR
Cell; 2005 Aug; 122(3):337-49. PubMed ID: 16096055
[TBL] [Abstract][Full Text] [Related]
17. Beta cell expression of IGF-I leads to recovery from type 1 diabetes.
George M; Ayuso E; Casellas A; Costa C; Devedjian JC; Bosch F
J Clin Invest; 2002 May; 109(9):1153-63. PubMed ID: 11994404
[TBL] [Abstract][Full Text] [Related]
18. Loss of TFB1M results in mitochondrial dysfunction that leads to impaired insulin secretion and diabetes.
Sharoyko VV; Abels M; Sun J; Nicholas LM; Mollet IG; Stamenkovic JA; Göhring I; Malmgren S; Storm P; Fadista J; Spégel P; Metodiev MD; Larsson NG; Eliasson L; Wierup N; Mulder H
Hum Mol Genet; 2014 Nov; 23(21):5733-49. PubMed ID: 24916378
[TBL] [Abstract][Full Text] [Related]
19. Diabetic pancreatic beta cells ARNT all they should be.
Levisetti MG; Polonsky KS
Cell Metab; 2005 Aug; 2(2):78-80. PubMed ID: 16098823
[TBL] [Abstract][Full Text] [Related]
20. Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet beta cells.
Bernal-Mizrachi E; Fatrai S; Johnson JD; Ohsugi M; Otani K; Han Z; Polonsky KS; Permutt MA
J Clin Invest; 2004 Oct; 114(7):928-36. PubMed ID: 15467831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
